Mirum Pharmaceuticals Inc. - notizie pubblicate 221 - letture 2.962
MIRUM PHARMACEUTICALS INC.
Insider Trading Report (SEC Filing - 4)
The text version of this document is not available. you can access the original document here. attachments original document permalink disclaimer mirum pharmaceuticals inc. publish ...
MIRUM PHARMACEUTICALS INC.
Initial Insider Trading Report (SEC Filing - 3)
Sec form 3sec form 3 form 3 united states securities and exchange commission washington, d.c. 20549 initial statement of beneficial ownership of securities filed pursuant to sectio ...
MIRUM PHARMACEUTICALS INC.
Insider Trading Report (SEC Filing - 4)
Joint filer information names: deerfield mgmt iv, l.p., deerfield mgmt hif, l.p., deerfield management company, l.p., deerfield private design fund iv, l.p., deerfield healthcare i ...
MIRUM PHARMACEUTICALS INC.
Insider Trading Report (SEC Filing - 4)
The text version of this document is not available. you can access the original document here. attachments original document permalink disclaimer mirum pharmaceuticals inc. publish ...
MIRUM PHARMACEUTICALS INC.
Initial Insider Trading Report (SEC Filing - 3)
Sec.gov | request rate threshold exceeded u.s. securities and exchange commission your request originates from an undeclared automated tool to allow for equitable access to all use ...
MIRUM PHARMACEUTICALS INC.
Insider Trading Report (SEC Filing - 4)
Sec form 4sec form 4 form 4 united states securities and exchange commission washington, d.c. 20549 statement of changes in beneficial ownership filed pursuant to section 16(a) of ...
MIRUM PHARMACEUTICALS INC.
Insider Trading Report (SEC Filing - 4)
The text version of this document is not available. you can access the original document here. attachments original document permalink disclaimer mirum pharmaceuticals inc. publish ...
MIRUM PHARMACEUTICALS INC.
Insider Trading Report (SEC Filing - 4)
Sec form 4sec form 4 form 4 united states securities and exchange commission washington, d.c. 20549 statement of changes in beneficial ownership filed pursuant to section 16(a) of ...
MIRUM PHARMACEUTICALS INC.
Insider Trading Report (SEC Filing - 4)
Sec.gov | request rate threshold exceeded u.s. securities and exchange commission your request originates from an undeclared automated tool to allow for equitable access to all use ...
MIRUM PHARMACEUTICALS INC.
Insider Trading Report (SEC Filing - 4)
Sec.gov | request rate threshold exceeded u.s. securities and exchange commission your request originates from an undeclared automated tool to allow for equitable access to all use ...
MIRUM PHARMACEUTICALS INC.
Insider Trading Report (SEC Filing - 4)
Sec form 4sec form 4 form 4 united states securities and exchange commission washington, d.c. 20549 statement of changes in beneficial ownership filed pursuant to section 16(a) of ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti